close btn
  • JAPANESE
  • TOP
  • Welcome Message
  • Overview
  • Call for Abstracts
  • Conflict of Interest 
  • Program
  • Information for Participants
  • Schedule
  • Venue 
  • Accommodation 
  • Link

The 105th Congress of the Japan Gastroenterological Endoscopy Society

menu btn

Call for Abstracts

  1. 1. Abstracts in English
  2. 2. Submission Period
  3. 3. Requirements
  4. 4. Presentation & Category Type
  5. 5. Instruction for Preparing Abstract
  6. 6. Notification of Receiving Abstract
  7. 7. Notification of Acceptance of Abstract
  8. 8. Privacy Policy
  9. 9. Abstract Submission
  10. 10. Contact Information

1. Abstracts in English

Submissions for core sessions and general presentations must be submitted online from the JGES website.
Please click "Abstract Submission" at the bottom of this page.

2. Submission Period

Open: 12:00pm Wednesday, September 21, 2022 (JST)
Close: Tuesday, November 8, 2022 (JST)Thursday, November 24,2022(JST)
   Abstract Submission is now closed. Thank you for your submission.
*The designated speakers requested by the Acting Secretariat of the 105JGES will be contacted separately.

3. Requirements

● Please carefully read the following notifications before your abstract submission.

  1. The abstract should be unpublished at the Annual Meeting of the Japan Gastroenterological Endoscopy Society (JGES) and the other scientific meetings.
    Notice: The accepted abstracts for the international sessions will be published in Digestive Endoscopy.
  2. No conflict with ethical regulations
    Medical research involving human subjects, including research on samples and data of human origin, should be approved by the Ethics Committee, and informed consent should be obtained in accordance with the Declaration of Helsinki. If an ethical issue is suspected by the Editorial Board, it will be discussed by the Ethics Committee of the Society. To protect the privacy of individuals, please refrain from using expressions that may identify individuals in the images and other materials presented.
  3. Conflict of Interest
    Before you submit the abstract, please be sure to read through “Conflict of Interest” page.
  4. The conference proceedings will be available through an app for smartphones and tablets.
    Please understand that the accepted abstracts will be electronically published.
  5. You cannot apply for more than one doctor from the same organization to submit the same subject as the first author. In this case, please note that both abstracts will be withdrawn.
    However, if the first author belongs to a different organization, they can apply as a co-presenter. If you are submitting an abstract for a multi-institutional study, please use the name of the organization, or use a title that identifies the study as a multi-institutional study.
  6. You cannot submit the same contents in different categories. Abstracts considered to be the same will be discussed by the reviewers and program committee. Please note that when the abstracts are judged to be identical, both will be rejected. For categories, please see 4. Categories and Presentation type.
  7. Withdrawal and absence
    Please be aware that any author that withdraws an abstract after acceptance notification or is absent without notice on the day of presentation may possibly be penalized according to the rules of JGES.

4. Presentation & Category Type

Presentation type *Please choose one.

  1. Apply for theme sessions: Withdraw the abstract if not accepted
  2. Apply for theme sessions: Oral Presentation if not accepted
  3. Apply for theme sessions: Poster Presentation if not accepted
  4. Apply for theme sessions: Oral or Poster（Either Presentation）if not accepted
  5. Oral Presentation preferred
  6. Poster Presentation preferred
  7. Oral or Poster （Either Presentation）

Presentation Language

English on abstract, presentation slides, presentation and discussion

*Important Notification
After your presentation is accepted, please be sure to complete registration, including paying the registration fee.

Theme Sessions Call for Abstract

Symposium

Innovative synergy in the collaboration of surgical and endoluminal approaches.

>>Introduction

The technology of endoscopic interventions has been steadily developing and providing us a series of novel less-invasive alternatives to surgery. However, the application had been confined within the gut wall for many years considering the risk of formidable extraluminal soiling with luminal contents by inadvertently breaking the integrity of the gut wall. Contrarily, we now greatly appreciate the synergy of the collaboration of endoscopists and surgeons with different skill and knowledge bases in various occasions and clinical settings day to day basis. The synergy has improved the safety of our practices and made the deeper layers of the gut wall and even extraluminal cavities working fields of endoscopic interventions. In this symposium, we would like to discuss and clarify the benefit of the collaboration of surgical and endoluminal approaches based on available clinical evidence regardless of target disease.

close
Panel Discussion

Clinical practice update by evaluation of endoscopic mucosal healing in inflammatory bowel disease

>>Introduction

Endoscopic evaluation is the gold standard for the diagnosis and disease activity monitoring of inflammatory bowel disease (IBD). Treat to target (T2T) strategy has been proposed and mucosal healing is considered as the ideal goal which contributes to the improvement of long-term clinical outcomes, such as a reduction of surgery and hospitalization. However, it has not been established about the timing, endoscopic modalities to be used, and scoring system for the evaluation of mucosal healing of IBD. Recent reports show that artificial intelligence (AI) technology is promising for the evaluation of mucosal healing, but its role has yet to be determined. In this workshop, we would like to invite to present researches performed from various aspects to discuss optimal endoscopic evaluation and treatment strategies for the improvement of long-term prognosis of IBD.

close
Workshop

Endoscopy with artificial intelligence and molecular imaging

>>Introduction

Artificial intelligence (AI) is attracting great attention as an innovative technology in medicine. AI deep learning enabled the establishment of a computer-aided diagnosis (CAD) system with high accuracy in gastrointestinal endoscopy. Several AI-based CAD systems for endoscopy have been approved in Japan and several countries. Positive results of large-scale randomized controlled trials on AI-based CAD are encouraging the dissemination of this technology. Meanwhile, molecular imaging which visualizes tumor cells by targeting tumor-specific molecule is rapidly developing, and is expected to enable highly sensitive endoscopic detection of early neoplastic lesions in endoscopic research. However, the actual role of AI and molecular imaging in endoscopy has not yet been established. In this workshop, we would like to clarify their current status and discuss how these technologies should be clinically applied.

close

Issues regarding endoscopic diagnosis and treatment of Barrett's esophageal adenocarcinoma

>>Introduction

Recently, Barrett's esophageal adenocarcinoma has been increasing in Japan as well as in Western countries, but there are large differences in endoscopic diagnosis and surveillance methods for Barrett's esophagus between Japan and the West.　In addition, there are many issues that need to be resolved, such as the difficulty in endoscopic diagnosis of adenocarcinoma in long-segment Barrett’s esophagus, and clarification of the long-term prognosis of patients who underwent endoscopic treatment for Barrett's esophageal adenocarcinoma, which is still unclear in spite of the popularity of this treatment. In this workshop, we would like to contribute to the establishment of Barrett's esophageal adenocarcinoma treatment and to its future progress by discussing the current problems in the endoscopic diagnosis and treatment of Barrett's esophageal adenocarcinoma. We invite many abstract submissions, including proposals for new techniques for endoscopic diagnosis, treatment, and surveillance methods for Barrett's esophageal adenocarcinoma.

close

The inquiry for recent guidelines of surveillance to inflammatory bowel disease associated neoplasia

>>Introduction

The number of IBD patients in Japan are increasing continuously, and long-term cases eligible for the surveillance to IBD-related neoplasia are also increasing. The surveillance for IBD-related neoplasia is an ongoing topic of discussion at national and international congress, and the guidelines for the practice of IBD-related neoplasia by the Japanese Society for Cancer of the Colon and Rectum are scheduled for publication in early 2023. Many issues remain in this field, including epidemiological studies, prognosis, optimization and promoting efficiency of surveillance endoscopy, indications and techniques for endoscopic resection, pros and cons and indications for partial surgical resection, pathological differential diagnosis between IBD-related neoplasia and sporadic tumors, and use of endoscopy and the other methods differently in patients with Crohn's disease. In this session, we would like to call papers on the issues raised by domestic and international guidelines, as well as researches at individual institutions, to actively discuss from various angles the optimal approach of surveillance for IBD-related neoplasia and future directions, with an eye toward the next revision of the guidelines. We look forward to receiving many aggressive abstract submissions.

close

Categories and Presentation type

○Content Category 1 *Please choose one.

01 Oral and oropharyngeal 06 Large intestine
02 Esophageal 07 Biliary
03 Gastric 08 Pancreatic
04 Duodenal 09 Hepatic
05 Small intestine 10 Other

○Content Category 2 *Please choose two preferences.

1 Neoplasm 18 Endoscopic hemostasis
2 Functional disease 19 Varicosis treatment
3 Infectious disease（Including H. pylori） 20 Ultrathin endoscopes (including perinasal endoscopy)
4 Inflammatory disease 21 Ultrathin endoscopes (including perinasal endoscopy)
5 Image management systems 22 Capsule endoscopy
6 Image analysis and processing 23 Intestinal endoscopy
7 Endoscope cleaning and disinfection 24 Gastrostomy
8 Pretreatment and perioperative management 25 Stents and dilation
9 Sedation 26 Laser treatment and PDT
10 Education and training 27 Diagnostic laparoscopy
11 Risk management (including elderly patients) 28 Laparoscopic surgery
12 Magnification, high-magnification, and image-enhancing endoscopy 29 Foreign body removal
13 ESD and EMR 30 Obesity treatment
14 New minimally invasive endoscopy 31 Notes
15 EUS 32 POEM
16 EUS and FNA technique 33 Other
17 ERCP and ERCP-related technique    

Poster sessions

The poster presentation format will be announced in Spring 2023.

5. Instruction for Preparing Abstract

Abstracts should be prepared in the following manners:

  1. Refer to the glossary of JGES and use appropriate terminology.
    If you are a member of JGES, the 4th edition of the Glossary of Gastrointestinal Endoscopy is available. Member’s number and password are required to review.
  2. Author:
    Maximum number of authors (first author + co-authors): 20 or less
    *Please note that if your presentation is accepted as Theme Sessions, up to two co-authors will be listed on the online abstract.
    *For details on how to register, please refer to the registration page.
  3. Abstract body:
    There should be within 1,800 one-byte characters including title, authors' names and affiliations and spaces.
    *In case of using pictures and/or graphs, the abstract body should be within 1,200 one-byte characters including title, authors' names and affiliations and spaces.
    *Please refer to the registration page for further detail.
  4. Maximum number of affiliated institutions:
    Up to 10 institutions

6. Notification of Receiving Abstract

After submitting your abstract, you will receive a completion e-mail, which will serve as a notification of the receipt of your abstract submission. For security reasons, we will not respond to any inquiries about your password after registration. If you lose your password, you will be required to register again. The abstract with the lost password will be discarded. If you wish to delete an abstract for which you have lost your password, please contact the secretariat by e-mail (endai-105jges@convention.co.jp).

7. Notification of Acceptance of Abstract

You will be notified of the acceptance or rejection of your abstract at the e-mail address you entered when you submitted your abstract. Please be sure to enter a valid e-mail address that you check regularly, as we will send you important information by e-mail.

8. Privacy Policy

The 105JGES entrusts the personal information, such as name, contact information, and e-mail address, collected at the abstract submission for this conference will be used for inquiries from the secretariat and notification of presentations. Names, affiliations, abstract titles, and the text of abstracts will be used only for the purpose of publishing them on the website and in the abstract collection and will not be used for any purposes other than stated above. After the conference, we will ensure that information is protected from outside parties.

9. Abstract Submission

Theme Session
Abstract Submission

Theme Session
Confirmation / Modification

Others
Abstract Submission

Others
Confirmation / Modification

*Before you submit the abstract, please read the instruction to understand the purpose of the session.

10. Contact Information

Secretariat of 105JGES
c/o Japan Convention Services, Inc.
14F Daido Seimei Kasumigaseki Bldg.
1-4-2, Kasumigaseki, Chiyoda-ku,
Tokyo 100-0013, Japan
E-mail： endai-105jges@convention.co.jp

Secretariat Office

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Iwate Medical University

2-1-1, idaidori, Shiwa-gun Yahaba-cho, Iwate 028-3695 Japan

Congress Secretariat

c/o Japan Convention Services, Inc.

E-mail：105jges@convention.co.jp

©The 105th Congress of the Japan Gastroenterological Endoscopy Society